Literature DB >> 25081091

Toll-like receptor signalling through macromolecular protein complexes.

Clare E Bryant1, Martyn Symmons2, Nicholas J Gay3.   

Abstract

The molecular mechanisms by which pattern recognition receptors (PRRs) signal are increasingly well understood. Toll-like receptor 4 (TLR4) signals through two separate pairs of adaptor proteins Mal/MyD88 and Tram/Trif. Structural studies have revealed a common theme for PRR signalling in that their signalling proteins form large macromolecular complexes which are thought to form the active signalling complex. The first of these to be characterised was the MyD88 signalling complex Myddosome. Many questions remain unanswered however. In particular it is unclear whether these signalling complexes form within the living cell, how many of each signalling protein is within the intracellular Myddosome and whether the stoichiometry can vary in a ligand-dependent manner. In this review we will discuss what is known about the macromolecular complexes thought to be important for TLR4 signalling.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Myddosome; Toll-like receptor 4

Mesh:

Substances:

Year:  2014        PMID: 25081091     DOI: 10.1016/j.molimm.2014.06.033

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  27 in total

Review 1.  Potential functions of esophageal cancer-related gene-4 in the cardiovascular system.

Authors:  Rui Zhou; Yuanshu Liu; Wenjun Huang; Xitong Dang
Journal:  Front Med       Date:  2019-08-29       Impact factor: 4.592

Review 2.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

3.  Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.

Authors:  Stefano G Daniele; Dawn Béraud; Connor Davenport; Kui Cheng; Hang Yin; Kathleen A Maguire-Zeiss
Journal:  Sci Signal       Date:  2015-05-12       Impact factor: 8.192

Review 4.  Lipopolysaccharide Detection across the Kingdoms of Life.

Authors:  Jonathan C Kagan
Journal:  Trends Immunol       Date:  2017-05-24       Impact factor: 16.687

Review 5.  Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Nevena Jeremic; George H Kunkel; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

6.  Aqueous Extract of Cimicifuga dahurica Reprogramming Macrophage Polarization by Activating TLR4-NF-κB Signaling Pathway.

Authors:  Shushu Qian; Xuan Han; Xiaocao Sha; Fang Tian; Hong Huang; Pengjun Jiang; Guoshun Huang; Bangyun Ma; Hong Zhang; Yiye Zhu; Xuemei Sun
Journal:  J Inflamm Res       Date:  2022-02-15

7.  CD200Fc reduces TLR4-mediated inflammatory responses in LPS-induced rat primary microglial cells via inhibition of the NF-κB pathway.

Authors:  Li Jiang; Fan Xu; Wenjing He; Lifei Chen; Haibin Zhong; Yu Wu; Siming Zeng; Li Li; Min Li
Journal:  Inflamm Res       Date:  2016-03-08       Impact factor: 4.575

8.  Chloroquine attenuates LPS-mediated macrophage activation through miR-669n-regulated SENP6 protein translation.

Authors:  Yupeng Long; Xin Liu; Ning Wang; Hong Zhou; Jiang Zheng
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

9.  Paying the Toll for Glucose Regulation: A Central Role for TLR3.

Authors:  Matthew D Woolard; Christopher G Kevil
Journal:  Diabetes       Date:  2015-10       Impact factor: 9.461

10.  Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats.

Authors:  Jia-Ji Lin; Yi Du; Wen-Ke Cai; Rong Kuang; Ting Chang; Zhuo Zhang; Yong-Xiang Yang; Chao Sun; Zhu-Yi Li; Fang Kuang
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.